The following is a schedule of financial highlights for the three months ended March 31, 2026 and 2025.
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
2026 |
|
|
2025 |
|
Per Share Operating Performance |
|
|
|
|
|
|
Net Asset Value, Beginning of Period: |
|
$ |
25.26 |
|
|
$ |
25.33 |
|
Results of Operations:(1) |
|
|
|
|
|
|
Net Investment Income (Loss) |
|
|
0.65 |
|
|
|
0.54 |
|
Net Realized and Unrealized Gain (Loss) on Investments |
|
|
(0.20 |
) |
|
|
0.09 |
|
Increase (Decrease) in Net Assets Resulting from Operations |
|
|
0.45 |
|
|
|
0.63 |
|
Distributions to Shareholders |
|
|
|
|
|
|
Distributions from Net Investment Income |
|
|
(0.63 |
) |
|
|
(0.53 |
) |
Decrease in Net Assets Resulting from Distributions |
|
|
(0.63 |
) |
|
|
(0.53 |
) |
Net Asset Value, End of Period |
|
$ |
25.08 |
|
|
$ |
25.43 |
|
Shares Outstanding, End of Period |
|
|
18,631,636 |
|
|
|
10,715,270 |
|
Total return(2)(3) |
|
|
1.79 |
% |
|
|
2.49 |
% |
Net assets, end of period |
|
$ |
467,284 |
|
|
$ |
272,480 |
|
Ratio/Supplemental Data |
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
18,631,485 |
|
|
|
10,684,405 |
|
Ratio of net investment income (loss) to average net assets, without expense reimbursement(4) |
|
|
10.08 |
% |
|
|
8.80 |
% |
Ratio of net investment income (loss) to average net assets, with expense reimbursement(4) |
|
|
10.30 |
% |
|
|
9.30 |
% |
Ratio of total expenses to average net assets without reimbursement(4) |
|
|
10.57 |
% |
|
|
11.20 |
% |
Ratio of total expenses to average net assets with reimbursement(4) |
|
|
10.35 |
% |
|
|
10.80 |
% |
Asset coverage ratio(5) |
|
|
206.85 |
% |
|
|
193.80 |
% |
Portfolio turnover rate(3) |
|
|
2.68 |
% |
|
|
0.96 |
% |
(1)The per common share data was derived using weighted average shares outstanding. (2)Total return is calculated assuming a purchase of shares of common stock at the current net asset value on the first day and a sale at the current net asset value on the last day of the period reported. (5)Asset coverage ratio is presented as of March 31, 2026 and March 31, 2025, respectively.
|